These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9363994

  • 1. Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Chen T, Murai T, Mori S, Morimura K, Oohara T, Makino S, Tatematsu M, Wanibuchi H, Fukushima S.
    Carcinogenesis; 1997 Oct; 18(10):1877-82. PubMed ID: 9363994
    [Abstract] [Full Text] [Related]

  • 2. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Masui T, Murai T, Mori S, Oohara T, Makino S, Fukushima S, Tatematsu M.
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [Abstract] [Full Text] [Related]

  • 3. p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.
    Gen H, Yamamoto S, Morimura K, Min W, Mitsuhashi M, Murai T, Mori S, Hosono M, Oohara T, Makino S, Wanibuchi H, Fukushima S.
    Jpn J Cancer Res; 2001 Dec; 92(12):1278-83. PubMed ID: 11749692
    [Abstract] [Full Text] [Related]

  • 4. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K, Yamamoto S, Murai T, Mori S, Chen TX, Wanibuchi H, Fukushima S.
    Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
    [Abstract] [Full Text] [Related]

  • 5. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Masui T, Dong Y, Yamamoto S, Takada N, Nakanishi H, Inada K, Fukushima S, Tatematsu M.
    Cancer Lett; 1996 Jul 19; 105(1):105-12. PubMed ID: 8689624
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Min W, Lee CC, Salim EI, Wanibuchi H, Sukata T, Fukushima S.
    Cancer Lett; 1999 Jan 29; 135(2):137-44. PubMed ID: 10096421
    [Abstract] [Full Text] [Related]

  • 7. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA, Shirai T, Ogawa K, Takahashi S, Wild CP, Montesano R, Tsuda H, Ito N.
    Carcinogenesis; 1994 Dec 29; 15(12):2965-8. PubMed ID: 8001265
    [Abstract] [Full Text] [Related]

  • 8. Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models.
    Chen T, Yamamoto S, Kitano M, Murai T, Wanibuchi H, Matsukuma S, Nakatsuru Y, Ishikawa T, Fukushima S.
    Teratog Carcinog Mutagen; 1998 Dec 29; 18(3):101-10. PubMed ID: 9728794
    [Abstract] [Full Text] [Related]

  • 9. Infrequent involvement of microsatellite instability in urinary bladder carcinomas of the NON/Shi mouse treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Chen T, Yamamoto S, Gen H, Murai T, Mori S, Oohara T, Makino S, Wanibuchi H, Fukushima S.
    Cancer Lett; 1998 Jan 16; 123(1):41-5. PubMed ID: 9461016
    [Abstract] [Full Text] [Related]

  • 10. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin.
    Ozaki M, Shibata MA, Takahashi S, Orita SI, Kawabe M, Shirai T.
    Cancer Lett; 1997 May 19; 115(2):249-55. PubMed ID: 9149132
    [Abstract] [Full Text] [Related]

  • 11. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M [corrected to El-Baz M].
    J Natl Cancer Inst; 1995 Sep 20; 87(18):1383-93. PubMed ID: 7658499
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Don I, Takada N, Ogawa K, Shirai T, Fukushima S.
    Carcinogenesis; 1994 Oct 20; 15(10):2379-81. PubMed ID: 7955081
    [Abstract] [Full Text] [Related]

  • 13. Clonal analysis of urothelial carcinomas in C3H/HeN<-->BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Tatematsu M, Yamamoto M, Fukami H, Fukushima S.
    Carcinogenesis; 1998 May 20; 19(5):855-60. PubMed ID: 9635874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 16. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M, Deguchi M, Ribeiro-Filho L, Dahiya R.
    Cancer Res; 2001 Oct 01; 61(19):7101-9. PubMed ID: 11585741
    [Abstract] [Full Text] [Related]

  • 17. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H.
    Carcinogenesis; 2000 Jul 01; 21(7):1391-6. PubMed ID: 10874018
    [Abstract] [Full Text] [Related]

  • 18. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M.
    Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947
    [Abstract] [Full Text] [Related]

  • 19. Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice.
    Ogawa K, Uzvolgyi E, St John MK, de Oliveira ML, Arnold L, Cohen SM.
    Mol Carcinog; 1998 Jan 15; 21(1):70-9. PubMed ID: 9473773
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
    Cancer Res; 1997 Nov 01; 57(21):4765-76. PubMed ID: 9354438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.